About Oncovision
Oncovision is a company based in Boston (United States) founded in 2003 by Noriel Pavon was acquired by Bruker in September 2016. Oncovision has raised $3.84 million across 9 funding rounds from investors including Bruker, European Union and EIC Fund. Oncovision offers products and services including Mammi, Sentinella, Wprobe, and Caremibrain. Oncovision operates in a competitive market with competitors including Siemens Healthineers, Vayyar, Olympus, Niramai and Lantheus, among others.
- Headquarter Boston, United States
- Founders Noriel Pavon
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Oncovision, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Oncovision
Oncovision offers a comprehensive portfolio of products and services, including Mammi, Sentinella, Wprobe, and Caremibrain.
Provides precise imaging for breast cancer detection and diagnosis.
Assists in locating sentinel lymph nodes during cancer procedures.
Enables accurate detection for practical medical imaging applications.
Supports diagnosis and monitoring of Alzheimer's disease effectively.
Funding Insights of Oncovision
Oncovision has successfully raised a total of $3.84M across 9 strategic funding rounds. The most recent funding activity was a Grant round of $337.8 thousand completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Oncovision
Oncovision has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Bruker, European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
A private venture capital firm focused on life sciences investments.
|
Locked | Locked | Locked | |
|
ICO Axispart is engaged in providing financial solutions for businesses.
|
Locked | Locked | Locked |
Investor details for Oncovision
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Oncovision
Investment portfolio details for Oncovision
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Oncovision
Detailed financials for Oncovision
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Oncovision Comparisons
Peer comparison for Oncovision
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Oncovision
Oncovision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Siemens Healthineers, Vayyar, Olympus, Niramai and Lantheus, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based medical diagnostics are developed for healthcare applications.
|
|
| Locked | Locked | Locked |
Developer of 4D imaging sensors for cancer detection and other devices
|
|
| Locked | Locked | Locked |
Manufacturer of imaging and surgical products
|
|
| Locked | Locked | Locked |
Early breast cancer is detected using AI-based non-invasive thermal imaging.
|
|
| Locked | Locked | Locked |
Developer of diagnostic imaging agents and targeted therapeutics
|
|
| Locked | Locked | Locked |
Developer of diagnostic imaging and healthcare information technology systems for hospital use
|
Detailed competitors of Oncovision
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Oncovision
Complete news archive for Oncovision
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oncovision
Oncovision was founded in 2003 and raised its 1st funding round 3 years after it was founded.
Oncovision is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Oncovision is a funded company, having raised a total of $3.84M across 9 funding rounds to date.
Oncovision was founded in 2003 and is headquartered in Boston, United States. Medical and diagnostic devices focused on oncology imaging are produced by the company. Key product lines include the Sentinella intra-operative Gamma Camera and the MAMMI PET system, which enables visualization of small lesions and quantification of tumor activity in breast cancer diagnostics. Operations center on advancing oncology detection technologies.
Oncovision's top competitors include Olympus, Siemens Healthineers and United Imaging Healthcare.
Oncovision offers Mammi, Sentinella, Wprobe, and Caremibrain.
Oncovision has 6 investors. Key investors include Bruker, European Union, EIC Fund, CRB Inverbio, and ICO Axispart.